Is LASIK in China safe? Check, don't trust
Platforms, volumes & regulation at partner refractive centers · Researched July 2026 · Published August 2026
"Is it safe?" is really three questions: is the equipment the same, is the care competent, and what happens if something goes wrong. This page answers each with facts you can verify — the device names to ask for, what surgical volume does and doesn't buy you, and how hospital-based refractive care is structured — instead of asking you to take a sales page's word for it. The one thing no country changes: refractive surgery has real risks everywhere, and the decision that actually protects you is the diagnostic workup, made by the operating surgeon.
Question one: is the equipment the same?
Yes — and this is checkable, not a claim. Refractive lasers are built by a handful of global manufacturers, and a machine does not get configured to a lower standard for one market. The platform behind each procedure is the same product wherever it is installed:
| Procedure | Platform | Who makes it | The check |
|---|---|---|---|
| SMILE | VisuMax femtosecond laser | ZEISS (Germany) | SMILE only exists on ZEISS platforms — there is no off-brand version to be given |
| Femto-LASIK | Femtosecond + excimer pairing (e.g. WaveLight, MEL/VisuMax combinations) | Alcon (US/CH), ZEISS | Ask which femtosecond laser cuts the flap and which excimer does the ablation — a real center answers with model names |
| TransPRK | Surface-ablation excimer (e.g. Amaris) | SCHWIND (Germany) | Single-step "no-touch" TransPRK is a specific platform capability, not a technique any laser can do |
| EVO ICL | EVO/EVO+ Visian ICL lens | STAAR Surgical (US) | Every genuine ICL is made by one company; the lens implanted in Shanghai and the lens implanted in Los Angeles leave the same factory line |
Platform families in use at partner refractive centers, researched July 2026. Specific installed models vary by hospital and are confirmed in writing during scheduling — asking for them is normal, and the answer arriving quickly is itself a good sign.
These same platforms hold the relevant Western approvals in their home markets — SMILE on VisuMax and the EVO ICL are both FDA-approved in the United States — and in China each device must be registered with the NMPA, the national medical products regulator, before clinical use. The physics of your surgery does not know what country it is in.
Question two: is the care competent?
Here the honest answer favors China more than most first-time readers expect, for one structural reason: volume. China has the world's largest myopic population and concentrates refractive surgery in high-throughput hospital departments and national ophthalmic chains. The result, as the SMILE cost guide covers from the price angle, is that China performs more SMILE than the rest of the world combined, and the busiest Chinese refractive surgeons log annual case counts most Western practices would need many years to accumulate. Volume is not a guarantee of skill — but surgeon experience correlating with refined technique and complication management is one of the better-documented patterns in surgery, and it is the real engine behind both the quality and the hospital-scale pricing.
The second structural point: partner care is hospital-based. Refractive surgery in China grew up inside ophthalmology departments of large tertiary hospitals (the national tier system's top grade, colloquially "3A") and specialist eye hospitals, rather than in standalone laser storefronts. Practically, that means your surgery happens in a building with a full ophthalmology service behind it — retina, cornea, glaucoma — so the rare finding that needs a different specialist is a referral down a corridor, not a scramble. (For non-refractive eye surgery in China — cataract, glaucoma, retina — see our sister resource at eyesurgerychina.com; this site deliberately covers vision correction only.)
Question three: what are the actual risks?
The same ones as everywhere, and a page that lists them plainly is doing more for your safety than a page that promises you'll be fine. Common and usually temporary: dry eye in the early months, night glare and halos while healing settles. Uncommon: residual prescription needing an enhancement, LASIK flap-related issues. Rare and serious: infection, corneal ectasia after laser surgery on the wrong cornea, and for ICL — cataract formation, pressure rise, or long-term endothelial cell decline, which is why ICL carries an annual monitoring schedule for life. Screening exists to keep the wrong eyes out of surgery: the workup's tomography, pachymetry, and endothelial imaging are hunting for exactly the corneas and anterior chambers that turn a routine procedure into a risky one. That is why the workup — not the country — is the main safety event of the whole trip, and why the candidacy guide is the most important page on this site.
What safety actually turns on — anywhere
- Screening rigor. A center that measures more and declines more is safer than a center that says yes quickly — roughly one in five inquiries here ends up matched to a different procedure than the one asked about, and some to none. Diagnostics happen on day one, before surgery is confirmed; a surgeon who has reasons to say no is the product.
- Surgeon judgment on the margin. Thin corneas, suspicious topography, very high prescriptions — the cases in the options-map guide — are where centers differ. The question "what would rule me out?" tells you more about a provider than any before/after gallery.
- Aftercare structure. Records in English, a named contact channel, and a written enhancement policy — the fine-print page covers what to demand. A complication handled well is a safety property; a complication handled by an info@ inbox is not.
How to check any refractive center — eleven questions, and what a good answer sounds like
Everything above is a claim until you test it. These are the questions that separate a center that will screen you properly from one that will sell you a procedure — they are not China-specific, and they apply to us exactly as they apply to anyone else. The useful part is not the question; it is knowing what a real answer sounds like, because a weak center usually answers warmly rather than specifically.
- Which femtosecond and excimer laser models do you run, by name? Good: model names, in writing, within a day. Weak: "the latest German technology." Manufacturer and model is a fact, not a marketing choice.
- What would rule me out? Good: a specific list — corneal thickness floors, topography patterns, unstable prescription, dry-eye severity. Weak: "we can treat almost everyone." A center that cannot name its exclusions has not thought about them.
- What proportion of people who inquire do you end up declining, or redirecting to a different procedure? Good: a number, and it is not near zero. On this site roughly one in five inquiries ends up matched to a different procedure than the one asked about, and some to none.
- Is the full workup done on a separate day, before surgery is confirmed? Good: yes, unambiguously. Weak: a same-day workup-and-surgery slot. The three-day minimum exists because compressing those two into one day creates pressure to proceed that screening is designed to resist.
- Which measurements will you take, and may I have the raw numbers? Good: tomography, pachymetry, cycloplegic refraction, endothelial imaging for ICL — and yes, you can have your printouts. Weak: "our system handles that." What those numbers mean is published here so you can read your own.
- Who performs my surgery, and how do I know before the day? Good: a named surgeon, confirmed in advance. Weak: "one of our specialists." Not being told the name until you are gowned is its own answer.
- What is written down about enhancements — who pays, for how long, and under what conditions? Good: a written policy you can read before you book. Weak: a verbal reassurance. The fine print page covers what a real policy contains.
- What happens if something goes wrong after I fly home? Good: a named contact channel, records in English, and a stated route back. Weak: a generic inbox. A complication handled well is a safety property; a complication handled by an info@ address is not.
- Will I get my records in a language my own optometrist can read? Good: yes, as a document, before departure. This is the item most people forget to ask and most regret — your follow-up care happens at home.
- What is the full price, and what is excluded? Good: an itemized figure with the exclusions named. Weak: a headline number and a conversation later. Ours is itemized on the cost page.
- If the workup changes the recommendation, what happens to my schedule and my quote? Good: a stated policy — a laser-to-ICL reroute moves a three-day trip to six or seven days, so flexible return flights are standard advice. Weak: silence. This is the most common significant switch and it should not be a surprise.
If a center answers eight of these well and evades three, the three are the answer. None of this is a substitute for the diagnostic workup — it is how you decide whose workup to trust.
The sequence, records to home
Refractive surgery abroad runs through five stages, and the decision that matters is not the booking — it is day one, in person, after the measurements. Here is the whole path, including what can legitimately stop it at each point, because a route with no stopping points is not a safe route.
| Stage | What happens | Who decides | What can stop it here |
|---|---|---|---|
| 1. Records before you travel | You send your current prescription and any past eye history. If you wear contacts, they come out first — soft lenses days before the workup, rigid lenses weeks before. | You | Lenses still in: the measurements would be reading your contacts, not your eyes, and the workup has to be repeated after a washout. |
| 2. Remote read days to a week | A first read on plausible fit and likely procedure, plus an indicative price and trip length. It is an orientation, not a clearance. | Center, on paper only | An obvious mismatch — an unstable prescription, an age or condition that makes now the wrong time — is cheaper to find here than after a flight. |
| 3. Day-one workup in person | Corneal tomography, pachymetry, cycloplegic refraction, and for ICL anterior-chamber and endothelial imaging. Surgery is confirmed only after this, and the final quote with it. | The operating surgeon | This is the real gate. Thin corneas or suspicious topography can reroute you from laser to ICL — or rule out surgery altogether. The surgeon's right to say no is the protection you came for. |
| 4. Procedure day two onward | LASIK and SMILE: three days total, with the post-op check on day three. TransPRK: three to five. EVO ICL: six to seven, because departure waits on pressure and lens-vault checks. | Surgeon | A same-day finding on the eye, or a lens size not in inventory for ICL, can move the date. A schedule that cannot move is a warning, not a convenience. |
| 5. Home the long tail | You leave with records in English, a drop schedule, a named contact, and a written enhancement policy. ICL adds an annual monitoring schedule for life. | You and your home optometrist | Nothing stops here — which is the point. Aftercare is the stage most easily under-planned, and the one that runs longest. |
Trip lengths as published on the how long to stay page; entry routes, including whether the 240-hour visa-free transit applies to your passport, are covered per city — see Beijing. If you are making the trip without a companion, the traveling alone page covers the days you cannot read a screen.
Questions people actually ask
Is LASIK in China safe?
The checkable facts: major Chinese refractive centers operate the same devices as Western clinics — ZEISS VisuMax for SMILE, Alcon WaveLight and similar excimer platforms for LASIK and TransPRK, and the STAAR Surgical EVO ICL, each carrying the same manufacturer specifications everywhere it is installed. China performs more SMILE procedures than any other country, so per-surgeon case volumes at the large centers are among the highest in the world, and partner care is hospital-based rather than storefront. None of that guarantees an outcome — refractive surgery carries the same real risks in every country — which is why the honest answer is that safety turns on screening rigor and surgeon judgment, and the final call on whether you should have surgery at all belongs to the operating surgeon after a full diagnostic workup.
Do Chinese hospitals use the same LASIK machines as clinics in the US or Europe?
The platforms are the same products from the same manufacturers: SMILE is performed on ZEISS VisuMax femtosecond lasers (the only platform SMILE exists on, anywhere), LASIK on femtosecond-plus-excimer combinations from makers such as ZEISS and Alcon, TransPRK on surface-ablation excimer systems such as SCHWIND Amaris, and EVO ICL is a single global product manufactured by STAAR Surgical — the lens implanted in Shanghai comes from the same company as the lens implanted in Los Angeles. A laser cannot be configured to a lower standard for one market; what varies between clinics anywhere is screening quality and surgical skill, not the physics.
Why do refractive surgeons in China have such high case volumes?
Scale. China has a very large myopic population and refractive surgery is concentrated in high-throughput hospital departments and national chains, so China performs more SMILE than the rest of the world combined and its busiest surgeons log annual case counts that most Western practices would take many years to reach. Volume is not a guarantee of skill, but the correlation between surgical volume and refined technique is one of the better-documented patterns in surgery generally — and it is the honest reason a top Chinese refractive center can price at hospital-scale rates rather than boutique rates.
Is laser eye surgery in China regulated?
Yes. Medical devices — the lasers and the ICL lens — require registration with the NMPA (China's medical products regulator) before clinical use, hospitals operate under Ministry of Health licensing with a national tier system (the partner centers sit at or within top-tier '3A' institutions or national ophthalmic chains), and refractive surgery is performed by licensed ophthalmologists. Regulation sets the floor, not the ceiling: the difference between an adequate center and an excellent one is still screening rigor, surgeon experience, and honest patient selection — which is what you should be verifying regardless of country.
What are the real risks of LASIK, SMILE or ICL — in China or anywhere?
The same list worldwide: dry eye that is common early and usually settles, night glare and halos that usually fade, residual prescription that occasionally needs an enhancement, flap-related issues specific to LASIK, and rare but serious complications — infection, corneal ectasia after laser surgery, and for ICL, cataract, pressure rise, or endothelial cell decline. Good screening exists precisely to keep the wrong eyes out of surgery, which is why the diagnostic workup — not the country — is the main safety event, and why no honest provider anywhere promises an outcome.
How do I verify which devices a hospital actually uses?
Same manufacturers, same models — SMILE only exists on ZEISS VisuMax, and every EVO ICL comes from STAAR Surgical. Ask any center for its device model names; a real one answers in writing.
What is the single biggest risk in refractive surgery?
Having surgery on eyes that shouldn't have it. The rare serious complications cluster in poorly screened cases, which is why the day-one diagnostic workup is the main safety event and the surgeon's right to say no is your best protection.
Should a hospital's high patient volume worry me?
Throughput is high by Western standards — that's the model, and it's what the pricing reflects. The parts that shouldn't be fast are the workup and the consent conversation; if either feels rushed at any center, in any country, walk.